168 related articles for article (PubMed ID: 35772016)
21. Susceptibilities of
Wang K; Cheng L; Li W; Jiang H; Zhang X; Liu S; Huang Y; Qiang M; Dong T; Li Y; Wang J; Feng S; Li H
Heliyon; 2020 Jun; 6(6):e04203. PubMed ID: 32613106
[TBL] [Abstract][Full Text] [Related]
22. Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
Almeida-Paes R; Brito-Santos F; Figueiredo-Carvalho MHG; Machado ACS; Oliveira MME; Pereira SA; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Mem Inst Oswaldo Cruz; 2017 May; 112(5):376-381. PubMed ID: 28443986
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
[TBL] [Abstract][Full Text] [Related]
24. [In vitro sensitivity of Paracoccidioides brasiliensis to systemically used antifungal agents].
Rodero L; Canteros CE; Rivas C; Lee W; Davel G
Rev Argent Microbiol; 1999; 31(2):78-81. PubMed ID: 10425663
[TBL] [Abstract][Full Text] [Related]
25. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Espinel-Ingroff A; Diekema DJ; Fothergill A; Johnson E; Pelaez T; Pfaller MA; Rinaldi MG; Canton E; Turnidge J
J Clin Microbiol; 2010 Sep; 48(9):3251-7. PubMed ID: 20592159
[TBL] [Abstract][Full Text] [Related]
26. MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM
J Antimicrob Chemother; 2020 May; 75(5):1194-1205. PubMed ID: 32025716
[TBL] [Abstract][Full Text] [Related]
27. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
[TBL] [Abstract][Full Text] [Related]
28. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
Velegraki A; Alexopoulos EC; Kritikou S; Gaitanis G
J Clin Microbiol; 2004 Aug; 42(8):3589-93. PubMed ID: 15297502
[TBL] [Abstract][Full Text] [Related]
29. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Rojas FD; Córdoba SB; de Los Ángeles Sosa M; Zalazar LC; Fernández MS; Cattana ME; Alegre LR; Carrillo-Muñoz AJ; Giusiano GE
Mycoses; 2017 Feb; 60(2):104-111. PubMed ID: 27625339
[TBL] [Abstract][Full Text] [Related]
30. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
[TBL] [Abstract][Full Text] [Related]
31. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
[TBL] [Abstract][Full Text] [Related]
32. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
33. Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
Zissova LG; Kantarjiev TB; Kuzmanov AH
Folia Med (Plovdiv); 2001; 43(3):10-2. PubMed ID: 11930825
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiology,
Li W; Zhang ZW; Luo Y; Liang N; Pi XX; Fan YM
J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
[No Abstract] [Full Text] [Related]
35. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.
Gupta AK; Kohli Y; Li A; Faergemann J; Summerbell RC
Br J Dermatol; 2000 Apr; 142(4):758-65. PubMed ID: 10792228
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
[TBL] [Abstract][Full Text] [Related]
37. In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.
Jang MJ; Shin JH; Lee WG; Kim MN; Lee K; Lee HS; Lee MK; Chang CL; Jang HC; Song ES; Kim SH; Shin MG; Suh SP; Ryang DW
Ann Lab Med; 2013 May; 33(3):167-73. PubMed ID: 23667842
[TBL] [Abstract][Full Text] [Related]
38. An azole-resistant isolate of Malassezia pachydermatis.
Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.
Cantón E; Pemán J; Hervás D; Iñiguez C; Navarro D; Echeverría J; Martínez-Alarcón J; Fontanals D; Gomila-Sard B; Buendía B; Torroba L; Ayats J; Bratos A; Sánchez-Reus F; Fernández-Natal I;
J Clin Microbiol; 2012 Dec; 50(12):3921-6. PubMed ID: 23015676
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
